BIOFRONTERA AG NA O.N./ DE0006046113 /
5/13/2024 8:18:04 AM | Chg. -0.0440 | Volume | Bid9:18:51 AM | Ask9:18:51 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
0.2980EUR | -12.87% | 0 Turnover: 0.0000 |
0.3120Bid Size: 1,000 | 0.3280Ask Size: 1,000 | 19.85 mill.EUR | 0.00% | 0.51 |
Assets
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | .6000 | .3000 | .3000 | .2000 | .3000 | ||||||
Intangible Assets | 1.7000 | 1.4000 | 1.3000 | 4.3000 | 3.8000 | ||||||
Long-Term Investments | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Fixed Assets | 2.3000 | 1.8000 | 1.5000 | 4.6000 | 4.1000 | ||||||
Inventories | 0.0000 | .1000 | .2000 | .5000 | .9000 | ||||||
Accounts Receivable | .1000 | 0.0000 | 0.0000 | 0.0000 | .3000 | ||||||
Cash and Cash Equivalents | .2000 | 1.4000 | .7000 | .6000 | 3.4000 | ||||||
Current Assets | 1.5000 | 1.6000 | 1.1000 | 1.1000 | 5 | ||||||
Total Assets | 3.8000 | 3.4000 | 2.6000 | 5.7000 | 9 |
Liabilities
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 1.9000 | .6000 | .5000 | .7000 | .7000 | ||||||
Long-term debt | 20.7000 | 11.3000 | 12.7000 | 10.6000 | 11.2000 | ||||||
Liabilities to Banks | 21.4000 | 12.6000 | 12.7000 | 16.9000 | 11.6000 | ||||||
Provisions | .5000 | .5000 | 2.2000 | .5000 | .7000 | ||||||
Liabilities | 23.9000 | 13.7000 | 15.5000 | 18.2000 | 14.2000 | ||||||
Share Capital | 3.3000 | 7.6000 | 10 | 11.2000 | 16.1000 | ||||||
Total Equity | -20.1000 | -10.4000 | -12.9000 | -12.5000 | -4.1000 | ||||||
Minority Interests | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Total liabilities equity | 3.8000 | 3.4000 | 2.6000 | 5.7000 | 9 |
Income Statement
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | .4000 | .3000 | .4000 | .5000 | 3.4000 | ||||||
Depreciation (total) | - | - | - | - | - | ||||||
Operating Result | -8.5000 | -5.4000 | -6.1000 | -4.4000 | -3.6000 | ||||||
Interest Income | - | - | - | - | - | ||||||
Income Before Taxes | -15.1000 | -3.3000 | -7.7000 | -4.6000 | -4.1000 | ||||||
Income Taxes | 0.0000 | .1000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Minority Interests Profit | 0.0000 | 0.0000 | 0.0000 | 0.0000 | 0.0000 | ||||||
Net Income | -15.1000 | -3.4000 | -7.7000 | -4.6000 | -4.1000 |
Per Share
Cash Flow
|
2008 IFRS in mill. EUR |
2009 IFRS in mill. EUR |
2010 IFRS in mill. EUR |
2011 IFRS in mill. EUR |
2012 IFRS in mill. EUR |
||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | -12.2000 | -3.7000 | -5.6000 | -4.7000 | -5.2000 | ||||||
Cash Flow from Investing Activities | 3.5000 | .4000 | 0.0000 | -.3000 | -.1000 | ||||||
Cash Flow from Financing | 4 | 4.5000 | 4.9000 | 4.8000 | 8.1000 | ||||||
Decrease / Increase in Cash | -4.7000 | 1.3000 | -.7000 | -.1000 | 2.8000 | ||||||
Employees | 28 | 23 | 20 | 27 | 34 |